Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy Sequenced vs Combined with EGFR-TKIs in NSCLC
NCT01746277Phase 2Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Oct 2012
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in non-small cell lung cancer (NSCLC), sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01746277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01746277.